Abstracts tagged "fibromyalgia"

Abstract Number: 233 • 2019 ACR/ARP Annual Meeting
Intensive CBT Is Effective in the Treatment of Significant Functional Impairment and Psychological Distress Found in Fibromyalgia: But Can We Improve Depressive Symptoms?
Barbara Bruce ¹, Madeleine Allman ², Jessica Gehin¹, Loretta Oliphant ¹, Fernando Rivera ¹ and Andy Abril ¹, ¹Mayo Clinic, Jacksonville, FL, ²Baylor College of Medicine, Houston, TX
Background/Purpose: The study was designed to evaluate the effectiveness and durability of an intensive cognitive behavioral intervention on functioning and depression in patients with Fibromyalgia…
Abstract Number: 2721 • 2019 ACR/ARP Annual Meeting
Subjective and Objective Dyscognition in Adolescents with Juvenile Fibromyalgia Syndrome
Sabrina Gmuca¹, Maitry Sonagra ², Rui Xiao ², Elizabeth Mendoza ², Kimberly S. Miller ³, Nina H. Thomas ¹, Pamela F. Weiss ¹, David D. Sherry ¹ and Jeffrey Gerber ², ¹Children's Hospital of Philadelphia, Philadelphia, PA, ²Children's Hospital of Philadelphia, Philadelphia, ³Children's Hospital fo Philadelphia, Philadelphia, PA
Background/Purpose: Dyscognition, including loss of mental clarity and problems with attention and memory, often affects adolescents with juvenile fibromyalgia syndrome (JFMS). Our understanding of this…
Abstract Number: 237 • 2019 ACR/ARP Annual Meeting
Determination of Muscle Pressure in Patients with Fibromyalgia by Two Examiners; The Examiners Get Similar Results
Alexandra Katz Small¹, Ben Small ², Jessica Polyak Wokurka ² and Robert Katz ³, ¹Rush University Medical Center, Chicago, ²Rheumatology Associates, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: Muscle pressure is increased in fibromyalgia as measured by a pressure gauge with a needle inserted into the trapezius muscle. We attempted to evaluate…
Abstract Number: 211 • 2019 ACR/ARP Annual Meeting
Effects of Deep Haptic Massage in Fibromyalgia (pilot Study)
aurore FELCE¹, aurore aubrun ¹, yacine allam ¹, Arnaud Choplin ¹, Liana Euller Ziegler ² and Véronique Breuil ³, ¹CHU Nice, nice, France, ²PUPH CHU NICE, nice, France, ³University of Nice, nice, France
Background/Purpose: The management of fibromyalgia is difficult, combining pharmacological and non-drug treatments, including massage. Its pathophysiology, still poorly understood, is complex, including muscle anomalies with…
Abstract Number: 238 • 2019 ACR/ARP Annual Meeting
Muscle Pressure as Measured by a Manometer Correlates with Dolorimetry in Patients with Fibromyalgia
Alexandra Katz Small¹, Ben Small ², Jessica Polyak Wokurka ² and Robert Katz ³, ¹Rush University Medical Center, Chicago, ²Rheumatology Associates, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: Muscle pressure is elevated in fibromyalgia patients compared to controls. We have demonstrated this finding in previous studies. We wanted to determine whether a…
Abstract Number: 212 • 2019 ACR/ARP Annual Meeting
Utility of Mood Disorders Questionnaire in Fibromyalgia: Data from the Cleveland Clinic Fibromyalgia Registry
Carmen Gota¹, Sahar Kaouk ², Kinanah Yaseen ¹, Nilamba Jhala ¹ and William Wilke ³, ¹Cleveland Clinic, Cleveland, OH, ²University of Dayton, Gates Mills, OH, ³Cleveland Clinic, Richmond Heights, OH
Background/Purpose: Patients with comorbid fibromyalgia syndrome (FMS) and bipolar disorder (BD) were found to have more severe FMS. The Mood disorders questionnaire (MDQ), a self-reported…
Abstract Number: 242 • 2019 ACR/ARP Annual Meeting
The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences
Robert Katz¹, Jessica Polyak Wokurka ² and Ben Small ², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: To assess patients’ global assessment of frequently used treatments for the fibromyalgia syndrome (FMS), we asked patients with fibromyalgia to rank medications they have…
Abstract Number: 216 • 2019 ACR/ARP Annual Meeting
Does Fibromyalgia Change the Evaluation of Spondyloarthritis Activity? A Meta-analysis of Observational Studies
Arthur Beck¹, Lilian SOLE ¹, Thomas Barnetche ² and Pascale Vergne-Salle ¹, ¹CHU de LIMOGES, LIMOGES, France, ²CHU de BORDEAUX, BORDEAUX, France
Background/Purpose: Recent studies evaluated the prevalence of Fibromyalgia (FM) in Spondyloarthritis (SpA) and its impact on disease activity scores, but none meta-analysis exists yet. Therefore,…
Abstract Number: 243 • 2019 ACR/ARP Annual Meeting
Concomitant Fibromyalgia in Patients with Other Rheumatic Diseases and Response to Treatment
Robert Katz¹, Jessica Polyak Wokurka ² and Ben Small ², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Some rheumatic disease patients have concomitant fibromyalgia. We wanted to determine treatment response in patients with and without concomitant fibromyalgia.Methods: Patients were diagnosed by…
Abstract Number: 218 • 2019 ACR/ARP Annual Meeting
Effects of Tai Chi versus Aerobic Exercise on Mindfulness in Fibromyalgia
Augustine Lee ¹, Lori Lyn Price ², Raveendhara Bannuru ³ and Chenchen Wang⁴, ¹Department of Physical Medicine and Rehabilitation, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, ²Tufts Medical Center, Tufts University, Boston, MA, ³Tufts Medical Center, Boston, MA, ⁴Tufts Medical Center, Boston
Background/Purpose: Emerging evidence shows that Tai Chi mind–body practice may result in greater benefits in pain and psychological symptoms of Fibromyalgia (FM). Mindfulness is the…
Abstract Number: 448 • 2019 ACR/ARP Annual Meeting
Central Sensitization in Patients with Rheumatoid Arthritis Using the Central Sensitization Inventory
Kentaro Noda¹, Moe Saitou ¹, Taro Ukichi ¹, Yohsuke Oto ¹, Ken Yoshida ¹ and Daitaro Kurosaka ¹, ¹The Jikei University School of Medicine, Tokyo, Japan
Background/Purpose: Pain of rheumatoid arthritis (RA) is thought to be nociceptive. However, recent studies indicate that RA pain also includes the mechanism of central sensitization…
Abstract Number: 219 • 2019 ACR/ARP Annual Meeting
A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI
Theodore Pincus¹, Isabel Castrejon ² and Joel Block ², ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: Fibromyalgia (FM) generally is easily recognized, but a diagnosis may be difficult, particularly in patients with secondary FM who have other primary diagnoses. Criteria…
Abstract Number: 683 • 2019 ACR/ARP Annual Meeting
Biologic Differences Between Type 1 and 2 Lupus
Megan Clowse¹, Jennifer Rogers ¹, Amanda Eudy ¹, Lisa Criscione-Schreiber ¹, Jayanth Doss ¹, Rebecca Sadun ¹, Kai Sun ¹, Micah McClain ², Ephraim Tsalik ³, Chris Woods ², David Pisetsky ⁴, Prathyusha Bachali ⁵, Amrie Grammer ⁶, Michelle Catalina ⁵ and Peter Lipsky ⁷, ¹Duke University, Durham, ²Duke University & Duke Center for Applied Genomics & Precision Medicine, Durham, ³Duke University, Duke Center for Applied Genomics & Precision Medicine, Durham VA, Durham, ⁴Duke University, Durham VAMC, Durham, ⁵AMPEL BioSolutions and the RILITE Research Institute, Charlottesville, VA, ⁶AMPEL BioSolutions and the RILITE Research Institute, Charlottesville, ⁷AMPEL BioSolutions, LLC, Charlottesville, VA
Background/Purpose: The manifestations of systemic lupus erythematosus (SLE) can be divided into categories according to a recently proposed model: a category of classic active autoimmune-driven…
Abstract Number: 220 • 2019 ACR/ARP Annual Meeting
A Positive Response to Nonpharmacological Therapies in Patients with Fibromyalgia
Raveendhara Bannuru¹, Michelle Park ², Lori Lyn Price ³ and Chenchen Wang ⁴, ¹Tufts Medical Center, Boston, MA, ²Tufts University School of Medicine, Boston, MA, ³Tufts Medical Center, Tufts University, Boston, MA, ⁴Tufts Medical Center, Boston
Background/Purpose: Identifying the factors associated with response to nonpharmacological therapies in patients with fibromyalgia will help personalize treatments and provide information to improve the design…
Abstract Number: 827 • 2019 ACR/ARP Annual Meeting
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia (FM): Evidence for a Broad Spectrum of Activity on the FM Syndrome
Gregory Sullivan¹, R. Michael Gendreau ², Judith Gendreau ³, Ashild Peters ⁴, Perry Peters ⁵ and Seth Lederman ⁶, ¹Tonix Pharmaceuticals Inc., New York, ²Gendreau Consulting, Poway, CA, ³Tonix Pharmaceuticals Inc, Poway, CA, ⁴Tonix Pharmaceuticals Inc., San Diego, CA, ⁵Tonix Pharmaceuticals Inc, San Diego, CA, ⁶Tonix Pharmaceuticals Inc, New York, NY
Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain, unrefreshing sleep, fatigue, and cognitive complaints. TNX-102 SL* is a sublingual (SL) formulation of cyclobenzaprine (CBP)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].